# A Device Study in Healthy Participants

> **NCT04848402** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 60 (actual)

## Conditions studied

- Healthy

## Interventions

- **DEVICE:** On-Body Delivery System (OBDS)/Multiple Bolus Injector
- **DEVICE:** Single Auto Injector
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04848402
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-27
- **Primary completion:** 2022-07-22
- **Final completion:** 2022-07-22
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04848402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04848402, "A Device Study in Healthy Participants". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04848402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*